MAPT and Alzheimer disease: ,18 In agreement with these observations, recent studies in the rodent forebrain reveal that VPS35 gene silencing is sufficient to induce tau pathology whereas pharmacological retromer stabilization is beneficial in an Alzheimer’s disease mouse model.19